<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Uratchat Vichaidit</style></author><author><style face="normal" font="default" size="100%">Pratya Phetkate</style></author><author><style face="normal" font="default" size="100%">Parunkul Tungsukruthai</style></author><author><style face="normal" font="default" size="100%">Kammal Kumar Pawa</style></author><author><style face="normal" font="default" size="100%">Panlop Chakkavittumrong</style></author><author><style face="normal" font="default" size="100%">Chuntida Kamalashiran</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effects of Hydrolyzed Marine Collagen Peptide Supplementation Combined with Phytonutrients on Skin Biophysical Parameters and Extracellular Matrix Biomarkers in Thai Women: A Prospective Clinical Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antera 3D</style></keyword><keyword><style  face="normal" font="default" size="100%">Barrier function</style></keyword><keyword><style  face="normal" font="default" size="100%">Cutometer</style></keyword><keyword><style  face="normal" font="default" size="100%">Fibrillin-1</style></keyword><keyword><style  face="normal" font="default" size="100%">Marine collagen peptides</style></keyword><keyword><style  face="normal" font="default" size="100%">Skin elasticity</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2026</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">18</style></volume><pages><style face="normal" font="default" size="100%">157-163</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Skin aging involves progressive deterioration of extracellular matrix components. This study investigated the effects of hydrolyzed marine collagen peptide supplementation combined with phytonutrients on skin biophysical parameters and dermal biomarkers in Thai women. &lt;strong&gt;Methods: &lt;/strong&gt;Sixtythree Thai women aged 40–60 years received daily supplementation (10,000 mg marine collagen peptides, Chlorella, grape seed extract, rice ceramides) for 12 weeks. Assessments included Antera 3D imaging, Cutometer elasticity measurements, Tewameter barrier function evaluation, and Corneometer hydration analysis. A subset (n=20) underwent suction blister biopsy for dermal biomarker analysis. &lt;strong&gt;Results: &lt;/strong&gt;Significant improvements were observed in Cutometer parameters: R5 net elasticity (p&amp;lt;0.001), R6 viscoelasticity (p=0.018), and R7 biological elasticity (p=0.003). Transepidermal water loss (TEWL) decreased by 12.1% (p=0.007). Antera 3D analysis revealed a significant increase in wrinkle width (p=0.021), indicating wrinkle flattening. Biomarker analysis showed significant increases in fibrillin-1 (+8.34%, p=0.005) and biglycan (+22.91%, p=0.036). Glogau photoaging classification improved in 23.8% of participants. &lt;strong&gt;Conclusions:&lt;/strong&gt; Marine collagen peptide supplementation combined with phytonutrients significantly improved skin elasticity and barrier function, with molecular evidence of extracellular matrix enhancement in Thai women.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">157</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Uratchat Vichaidit&lt;sup&gt;1&lt;/sup&gt;, Pratya Phetkate&lt;sup&gt;1&lt;/sup&gt;, Parunkul Tungsukruthai&lt;sup&gt;1&lt;/sup&gt;, Kammal Kumar Pawa&lt;sup&gt;1&lt;/sup&gt;, Panlop Chakkavittumrong&lt;sup&gt;2&lt;/sup&gt;, Chuntida Kamalashiran&lt;sup&gt;1*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Integrative Medicine, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, 12120, THAILAND.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Division of Dermatology, Department of Medicine, Faculty of Medicine, Thammasat University, Pathum Thani 12120, THAILAND&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Uratchat Vichaidit</style></author><author><style face="normal" font="default" size="100%">Chuntida Kamalashiran</style></author><author><style face="normal" font="default" size="100%">Kammal Kumar Pawa</style></author><author><style face="normal" font="default" size="100%">Pratya Phetkate</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Hydrolyzed Collagen Tonic Drink Prevents Worsening of Skin Parameters and Improves Photoaging Classification in Healthy Thai Women: A Randomized Controlled Trial</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Dermal aging</style></keyword><keyword><style  face="normal" font="default" size="100%">Hydrolyzed collagen</style></keyword><keyword><style  face="normal" font="default" size="100%">photoaging</style></keyword><keyword><style  face="normal" font="default" size="100%">Skin elasticity</style></keyword><keyword><style  face="normal" font="default" size="100%">Wrinkle</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">644-652</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Skin aging represents a significant public health burden globally, with Southeast Asian populations experiencing accelerated photoaging due to intensive environmental ultraviolet exposure. &lt;strong&gt;Aim: &lt;/strong&gt;To evaluate the preventive efficacy of hydrolyzed collagen tonic drink on skin aging parameters in healthy Thai women. &lt;strong&gt;Methods: &lt;/strong&gt;A double-blind, randomized controlled trial was conducted with 135 Thai women aged 40-60 years. Participants were randomized to receive either hydrolyzed fish collagen peptides with supportive nutrients (n=67) or active fruit juice control (n=68) daily for 12 weeks. Primary outcomes included skin microtopography parameters measured by Visioscan, skin elasticity assessed by Cutometer, and clinical photoaging classification using Glogau scale. Secondary outcomes examined molecular biomarker changes in procollagen Type I synthesis. &lt;strong&gt;Results:&lt;/strong&gt; The collagen group demonstrated significantly attenuated skin surface deterioration compared to placebo. The Wrinkles parameter showed significant betweengroup differences at week 8 (-100.43 units, p=0.001). Smoothness parameter exhibited protective effects with significant between-group differences at week 8 (-80.08 units, p=0.002). Gross elasticity improved significantly within the collagen group at week 12 (p=0.033). Procollagen Type I synthesis demonstrated superior maintenance in the collagen group versus placebo (between-group percent change difference, p=0.002). Both groups achieved comparable Glogau classification improvements (23.9% versus 20.6%). &lt;strong&gt;Conclusion: &lt;/strong&gt;Daily hydrolyzed collagen supplementation with supportive nutrients effectively prevented skin surface parameter deterioration in Thai women, demonstrating meaningful preservation of skin integrity through medium effect sizes for key parameters. These findings support nutritional approaches as complementary strategies for photoaging management in high ultraviolet-exposure populations&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">644</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Uratchat Vichaidit&lt;sup&gt;1&lt;/sup&gt;, Chuntida Kamalashiran&lt;sup&gt;1&lt;/sup&gt;, Kammal Kumar Pawa&lt;sup&gt;1&lt;/sup&gt;, Pratya Phetkate&lt;sup&gt;1*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Integrative Medicine, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, 12120, THAILAND.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Patnaree Wongmanit</style></author><author><style face="normal" font="default" size="100%">Kusuma Sriyakul</style></author><author><style face="normal" font="default" size="100%">Parunkul Tungsukruthai</style></author><author><style face="normal" font="default" size="100%">Ouppatham Supasyndh</style></author><author><style face="normal" font="default" size="100%">Pratya Phetkate</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Renal Resistive Index and Estimated Glomerular Filtration Rate in Nondiabetic Chronic Kidney Disease Stage 3: A Cross-Sectional Analytical Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">538-544</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Renal resistive index (RRI) and estimated glomerular filtration rate (eGFR) are predictive markers for chronic kidney disease (CKD) progression. &lt;strong&gt;Aim:&lt;/strong&gt; To evaluate RRI value, eGFRcr-cys and renal biomarker in nondiabetic patients with CKD stage 3 in Bangkok, Thailand. &lt;strong&gt;Methods:&lt;/strong&gt; A cross-sectional analytical analysis was conducted involving nondiabetic patients with CKD stage 3, aged 35-85 years. Ultrasound was used to assess the RRI of arteries in both kidneys. Patients underwent assessments of serum and urine 24-hour. &lt;strong&gt;Results:&lt;/strong&gt; Among the 61 participants (67.2% male; mean age 69.03 ± 12.59 years), the mean eGFRcr-cys was 41.63 ± 8.64 mL/min/1.73 m², and the mean RRI was 0.65 ± 0.06. Patients were categorized into three RRI groups: low (&amp;lt;0.65, n=35), intermediate (0.65-0.70, n=14), and high (&amp;gt;0.70, n=12). The high RRI group showed a mean RRI of 0.73 ± 0.05 (p &amp;lt; 0.01). Among those with high RRI group were significant decreased right kidney size (p&amp;lt;0.05) and they had a lower BMI, averaging 22.49 ± 3.48. An increase in PP (59.66 ± 13.84, p=0.04) was also significant in this group. The correlations coefficient of RRI value showed a significant positive correlation with age (p&amp;lt;0.05) and significant negative with BMI (p&amp;lt;0.05). In addition, eGFRcr-cys displayed a significant negative correlation with UAGT and 24hUP (p&amp;lt;0.05) and a significant while eGFRcr-cys positive correlation with both kidney size and urine iNOS(p&amp;lt;0.01). &lt;strong&gt;Conclusion:&lt;/strong&gt; An increase in RRI is inversely linked to age, BMI, and PP. Lower eGFR is correlated with factors that cause CKD progression.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">538</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Patnaree Wongmanit&lt;sup&gt;1&lt;/sup&gt;, Kusuma Sriyakul&lt;sup&gt;1&lt;/sup&gt;, Parunkul Tungsukruthai&lt;sup&gt;1&lt;/sup&gt;, Ouppatham Supasyndh&lt;sup&gt;2&lt;/sup&gt;, Sucharat Tungsukruthai&lt;sup&gt;3&lt;/sup&gt;, Pratya Phetkate&lt;sup&gt;1&lt;/sup&gt;*&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Integrative Medicine, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, 12120, THAILAND.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, Kasetsart University, Ngamwongwan Rd, Chatuchak, Bangkok 10900, THAILAND.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Division of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, THAILAND.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Patnaree Wongmanit</style></author><author><style face="normal" font="default" size="100%">Parunkul Tungsukruthai</style></author><author><style face="normal" font="default" size="100%">Pratya Phetkate</style></author><author><style face="normal" font="default" size="100%">Daraporn Rungprai</style></author><author><style face="normal" font="default" size="100%">Sucharat Tungsukruthai</style></author><author><style face="normal" font="default" size="100%">Ouppatham Supasyndh</style></author><author><style face="normal" font="default" size="100%">Kusuma Sriyakul</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Safety Assessment of Supplementation with Cymbopogon citratus Stapf. (Lemongrass) Extract in Patients with Chronic Kidney Disease Stage 3: A Preliminary 90-Days Prospective Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Chronic Kidney Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">CKD stage 3</style></keyword><keyword><style  face="normal" font="default" size="100%">Cymbopogon citratus Stapf.</style></keyword><keyword><style  face="normal" font="default" size="100%">Lemongrass</style></keyword><keyword><style  face="normal" font="default" size="100%">Safety</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">976-986</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Chronic kidney disease is a major public health issue, and due to resource constraints, many can't access dialysis. &lt;em&gt;C. citratus&lt;/em&gt;, lemongrass is globally prevalent and known to increase urine output without toxicity.&lt;strong&gt; Objective:&lt;/strong&gt; To examine the safety of &lt;em&gt;C. citratus&lt;/em&gt; in patients with CKD stage 3. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; The major compound of &lt;em&gt;C. citratus&lt;/em&gt; was analyzed using high-performance liquid chromatography (HPLC). 64 patients were enrolled and randomly assigned to control or &lt;em&gt;C. citratus&lt;/em&gt; groups. The control group received a placebo, whereas the &lt;em&gt;C. citratus&lt;/em&gt; group received 900 mg of &lt;em&gt;C. citratus&lt;/em&gt; daily for 90 days. All participants were examined BUN, Scr, Cys-C, and eGFR, liver functions, RBC, HCT, Na+, K+, Cl-, and HCO3, and other biochemical parameters. &lt;strong&gt;Results:&lt;/strong&gt; HPLC showed &lt;em&gt;C. citratus&lt;/em&gt; contains of phenolic compounds. Clinically, &lt;em&gt;C. citratus &lt;/em&gt;group had no notable side effects on T-Bil, AST, ALT and ALP. Also, maintained eGFR, SCys-C, K+ and Cl level. The level of blood Na+ was significant increase at day 30 (p &amp;lt; 0.05). The control group had a significant decrease in eGFR and HCO3 levels (p &amp;lt; 0.05) and a significant increase of Cl- and SCys-C. In addition, no statistical differences had found between groups in eGFR, BUN, Cr, Na&lt;sup&gt;+&lt;/sup&gt;, K&lt;sup&gt;+&lt;/sup&gt;, HCO3, PO4, RBC and HCT levels. Throughout the 90 days, no drug allergies or side effects were reported. &lt;strong&gt;Conclusion:&lt;/strong&gt; Dietary supplementation with &lt;em&gt;C. citratus&lt;/em&gt; may have a favorable effect on delaying the course of CKD and is safe to use for patients with CKD stage 3.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">976</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Patnaree Wongmanit&lt;sup&gt;1&lt;/sup&gt;, Parunkul Tungsukruthai&lt;sup&gt;1&lt;/sup&gt;, Pratya Phetkate&lt;sup&gt;1&lt;/sup&gt;, Daraporn Rungprai&lt;sup&gt;2&lt;/sup&gt;, Sucharat Tungsukruthai&lt;sup&gt;3&lt;/sup&gt;, Ouppatham Supasyndh&lt;sup&gt;4&lt;/sup&gt;, Kusuma Sriyakul&lt;sup&gt;1,&lt;/sup&gt;*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Integrative Medicine, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, 12120, THAILAND.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Pharmacy, Silpakorn University (Sanamchandra Palace Campus), Nakhon Pathom, 73000, THAILAND.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Division of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, THAILAND.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Faculty of Medicine, Kasetsart University, Chatuchak, Bangkok 10900, THAILAND.&lt;/p&gt;
</style></auth-address></record></records></xml>